Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug reimbursement
Pharma
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
A small patient population, a wait-and-see attitude and a “fairly significant” infrastructure barrier have slowed CSL's gene therapy rollout.
Angus Liu
Apr 11, 2025 10:32am
Pharma giants demand revamp of UK drug cost control policy
Mar 20, 2025 10:57am
NICE again rejects Alzheimer's drugs from Lilly and Biogen/Eisai
Mar 6, 2025 10:47am
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
Dec 4, 2024 12:52pm
Eisai, Biogen's Leqembi nabs UK nod but not reimbursement
Aug 22, 2024 9:23am
IRA negotiations slash prices for blockbuster drugs by up to 79%
Aug 15, 2024 9:00am
.jpg?VersionId=ZLTlFhjw6TAj8KSQ.fs.4fQfeszH7dHA)